We hypothesized that co-administration of APE or AN may
affect the cytochrome P450 family of enzymes and an herb–drug
interaction will impact the pharmacokinetics of ETO. To evaluate
further possible herb–drug interaction pharmacodynamic antiarthritic
study has been performed for the groups with co-administration
of APE, AN with ETO followed by histopathological
evaluation